Skip to main content
Taro Pharmaceutical Industries
WORLDWIDE SITES
USA
Canada
Israel
International
HOME
ABOUT US
History
PRODUCTS
USA
Canada
Israel
International
RESEARCH
INVESTOR RELATIONS
Investor Relations
Financials
Annual Reports
Fundamentals
Earnings & Proxy Reports
News Releases
Investor FAQ
E-mail Alerts
Contact Information
Safe Harbor
CONTACT
AFFILIATED WEBSITES
Taro U.S.A
Taro Canada
Taro Israel
Taro International
Sun Pharmaceutical Ind. Ltd
Sun Pharmaceutical USA
Chattem Chemicals Inc.
Contact
Text Size
A
A
A
Nortriptyline HCI Capsules, USP NDC 5167240011
Print
Home
» Nortriptyline HCI Capsules, USP NDC 5167240011
Submitted by
admin
on Fri, 04/23/2021 - 13:30
Certificates:
Nortriptyline HCI Capsules, USP NDC 5167240011.pdf
Log in
or
register
to post comments
